Celularity Stock Shares Outstanding
CELUW Stock | USD 0.02 0 5.29% |
Celularity fundamentals help investors to digest information that contributes to Celularity's financial success or failures. It also enables traders to predict the movement of Celularity Stock. The fundamental analysis module provides a way to measure Celularity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celularity stock.
Common Stock Shares Outstanding is likely to drop to about 11.8 M in 2024. Celularity | Shares Outstanding |
Celularity Company Shares Outstanding Analysis
Celularity's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Celularity Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Celularity is extremely important. It helps to project a fair market value of Celularity Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Celularity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Celularity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Celularity's interrelated accounts and indicators.
Click cells to compare fundamentals
Celularity Shares Outstanding Historical Pattern
Today, most investors in Celularity Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Celularity's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Celularity shares outstanding as a starting point in their analysis.
Celularity Shares Outstanding |
Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Celularity Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Celularity has 0.0 of shares currently outstending. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
All Next | Launch Module |
Celularity Fundamentals
Return On Equity | -1.54 | ||||
Return On Asset | -0.15 | ||||
Profit Margin | (2.64) % | ||||
Operating Margin | (0.84) % | ||||
Number Of Shares Shorted | 168.34 K | ||||
Revenue | 22.77 M | ||||
EBITDA | (35.91 M) | ||||
Net Income | (196.29 M) | ||||
Cash And Equivalents | 38 M | ||||
Cash Per Share | 0.27 X | ||||
Total Debt | 39.24 M | ||||
Debt To Equity | 0.18 % | ||||
Current Ratio | 2.29 X | ||||
Book Value Per Share | 1.27 X | ||||
Cash Flow From Operations | (38.69 M) | ||||
Earnings Per Share | (0.87) X | ||||
Number Of Employees | 120 | ||||
Beta | 0.51 | ||||
Total Asset | 143.89 M | ||||
Retained Earnings | (841.79 M) | ||||
Working Capital | (47.51 M) | ||||
Net Asset | 143.89 M |
About Celularity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Celularity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celularity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celularity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.